Working… Menu
Trial record 6 of 109 for:    CALCIUM CATION

A Study to Examine the Use of Zemplar to Increase Serum Calcium Levels in ICU Subjects

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00053378
Recruitment Status : Completed
First Posted : January 28, 2003
Last Update Posted : August 2, 2006
Information provided by:

Brief Summary:
A study to determine the effect of Zemplar on the regulation of serum calcium levels and the need for administration of elemental calcium in hypocalcemic intensive care patients

Condition or disease Intervention/treatment Phase
Hypocalcemia Drug: paricalcitol injection (Zemplar) Behavioral: Effects on calcium regulation Behavioral: Administration of elemental Ca during hypocalcemic ICU pts. Phase 2

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Enrollment : 45 participants
Allocation: Randomized
Intervention Model: Factorial Assignment
Masking: Double
Primary Purpose: Treatment
Official Title: A Placebo-Controlled, Double-Blind Study to Examine the Use of Zemplar to Increase Serum Calcium Levels in ICU Subjects
Study Start Date : January 2002

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Calcium

Primary Outcome Measures :
  1. The primary efficacy variable will be the change from Day 1 to last day of dosing in pH adjusted, serum ionized calcium levels.

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • ICU patients APACHE III score between 70 - 150 at screening and within 24 hours of enrollment and a whole blood ionized calcium level less than 0.90 mmol/L or corrected whole blood calcium level less than or equal to 7.5 mg/dL.

Exclusion Criteria:

  • Serum creatinine greater than 2.5 mg/dL

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00053378

Layout table for location information
United States, California
Merced Heart Association
Merced, California, United States, 95340
United States, Colorado
Denver Health Medical Center
Denver, Colorado, United States, 80204
United States, Florida
Outcomes Research Institute
Hudson, Florida, United States, 34667
Florida Hospital
Orlando, Florida, United States, 32803
United States, Illinois
University of Chicago
Chicago, Illinois, United States, 60637
United States, Kentucky
Central Baptist Hospital Clinical Research Center
Lexington, Kentucky, United States, 40503
United States, New York
Strong Memorial Hospital
Rochester, New York, United States, 14642
United States, Pennsylvania
St. Luke's Hospital
Bethlehem, Pennsylvania, United States, 18015
United States, Virginia
Heart Care Associates
Hopewell, Virginia, United States, 23860
Sponsors and Collaborators
Layout table for investigator information
Study Director: Joel Z Melnick, M.D. Abbott

Layout table for additonal information Identifier: NCT00053378     History of Changes
Other Study ID Numbers: M01-395
First Posted: January 28, 2003    Key Record Dates
Last Update Posted: August 2, 2006
Last Verified: July 2006
Keywords provided by Abbott:
hypocalcemia, ionized calcium, intensive care
Additional relevant MeSH terms:
Layout table for MeSH terms
Calcium Metabolism Disorders
Metabolic Diseases
Water-Electrolyte Imbalance
Calcium, Dietary
Calcium-Regulating Hormones and Agents
Physiological Effects of Drugs
Bone Density Conservation Agents